IP Verse

Safe And Effective Method Of Treating Ulcerative Colitis With Anti-Il12/Il23 Antibody

Patent No. EP3883606 (titled "Safe And Effective Method Of Treating Ulcerative Colitis With Anti-Il12/Il23 Antibody") was filed by Janssen Biotech on Sep 24, 2019. The application was issued on Nov 20, 2024.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (6)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
ACCORD HEALTHCAREApr 12, 2024BRAND MURRAY FULLER
KARO PATENTANWALTE KAHLHOFER ROSSLER KREUELS PARTG MBBApr 11, 2024-
KAROApr 11, 2024-
BIOCON BIOLOGICSApr 8, 2024MICHALSKI HUTTERMANN & PARTNER PATENTANWALTE MBB
SAMSUNG BIOEPISFeb 5, 2024SIMMONS & SIMMONS MUNICH
CAMULONJul 27, 2023REDDIE & GROSE

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3883606

JANSSEN BIOTECH
Application Number
EP19867085A
Filing Date
Sep 24, 2019
Status
Granted And Under Opposition
Jun 9, 2023
Publication Date
Nov 20, 2024
External Links
Slate, Register , Google Patents